Cargando...
Rituximab mediates loss of CD19 on B cells in the absence of cell death
OBJECTIVE: To evaluate loss of the B cell specific marker CD19 with addition of rituximab (RTX) to healthy donor blood and to determine the role of complement mediated cytotoxicity in these cells. METHODS: Healthy donor whole blood and peripheral blood mononuclear cells (PBMC) were evaluated for los...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3448861/ https://ncbi.nlm.nih.gov/pubmed/22674374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.34560 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|